{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:38:04Z","timestamp":1793813884872,"version":"4.6.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Health Science and Technology","award":["KJ20169"],"award-info":[{"award-number":["KJ20169"]}]},{"DOI":"10.13039\/501100016346","name":"Second Hospital of Tianjin Medical University","doi-asserted-by":"publisher","award":["MNRC202312"],"award-info":[{"award-number":["MNRC202312"]}],"id":[{"id":"10.13039\/501100016346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86607-6","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T03:55:55Z","timestamp":1737345355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and validation of biopsy free nomograms for predicting clinically significant prostate cancer in men with PI-RADS 4 and 5 lesions"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6654-9541","authenticated-orcid":false,"given":"Junxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5239-9933","authenticated-orcid":false,"given":"Mingzhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-4567","authenticated-orcid":false,"given":"Shanqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8060-3498","authenticated-orcid":false,"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3084-1655","authenticated-orcid":false,"given":"Xingkang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"1","key":"86607_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L. et al. Cancer statistics. CA Cancer J. Clin. 74 (1), 12\u201349. https:\/\/doi.org\/10.3322\/caac.21820 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"86607_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41585-022-00684-0","volume":"20","author":"MJ Connor","year":"2023","unstructured":"Connor, M. J. et al. Landmarks in the evolution of prostate biopsy. Nat. Rev. Urol. 20 (4), 241\u2013258. https:\/\/doi.org\/10.1038\/s41585-022-00684-0 (2023).","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"86607_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00345-023-04723-2","volume":"42","author":"S Vanoli","year":"2024","unstructured":"Vanoli, S. et al. Evolution of anxiety management in prostate biopsy under local anesthesia: a narrative review. World J. Urol. 42 (1), 43. https:\/\/doi.org\/10.1007\/s00345-023-04723-2 (2024).","journal-title":"World J. Urol."},{"issue":"2","key":"86607_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.eururo.2021.11.019","volume":"82","author":"VH Meissner","year":"2022","unstructured":"Meissner, V. H. et al. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur. Urol. 82 (2), 156\u2013160. https:\/\/doi.org\/10.1016\/j.eururo.2021.11.019 (2022).","journal-title":"Eur. Urol."},{"issue":"2","key":"86607_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.eururo.2022.03.008","volume":"82","author":"PK Modi","year":"2022","unstructured":"Modi, P. K. et al. Radical prostatectomy without biopsy: audacious, imprudent, or innovative? Eur. Urol. 82 (2), 161\u2013162. https:\/\/doi.org\/10.1016\/j.eururo.2022.03.008 (2022).","journal-title":"Eur. Urol."},{"issue":"5","key":"86607_CR6","doi-asserted-by":"publisher","first-page":"e223128","DOI":"10.1148\/radiol.223128","volume":"307","author":"B Turkbey","year":"2023","unstructured":"Turkbey, B. et al. PI-RADS: where next? Radiology 307 (5), e223128. https:\/\/doi.org\/10.1148\/radiol.223128 (2023).","journal-title":"Radiology"},{"key":"86607_CR7","first-page":"1","volume":"36","author":"S Remmers","year":"2021","unstructured":"Remmers, S. et al. Reducing biopsies and magnetic resonance imaging scans during the diagnostic pathway of prostate cancer: applying the rotterdam prostate cancer risk calculator to the PRECISION trial data. Eur. Urol. Open. Sci. 36, 1\u20138 (2021).","journal-title":"Eur. Urol. Open. Sci."},{"issue":"3","key":"86607_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41391-023-00660-8","volume":"26","author":"MR Siddiqui","year":"2023","unstructured":"Siddiqui, M. R. et al. Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy na\u00efve men. Prostate Cancer Prostat.  Dis. 26 (3), 588\u2013595. https:\/\/doi.org\/10.1038\/s41391-023-00660-8 (2023).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"1","key":"86607_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5534\/wjmh.220223","volume":"42","author":"JH Chung","year":"2024","unstructured":"Chung, J. H. et al. Nomogram using prostate health index for predicting prostate cancer in the gray zone: prospective, multicenter study. World J. Mens Health 42 (1), 168\u2013177. https:\/\/doi.org\/10.5534\/wjmh.220223 (2024).","journal-title":"World J. Mens Health"},{"issue":"4","key":"86607_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/pros.24658","volume":"84","author":"H Huang","year":"2024","unstructured":"Huang, H. et al. Based on PI-RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4\u201320 ng\/mL. Prostate 84 (4), 376\u2013388. https:\/\/doi.org\/10.1002\/pros.24658 (2024).","journal-title":"Prostate"},{"issue":"11","key":"86607_CR11","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.2967\/jnumed.121.263448","volume":"63","author":"L Emmett","year":"2022","unstructured":"Emmett, L. et al. The PRIMARY score: using intraprostatic 68Ga-PSMA PET\/CT patterns to optimize prostate cancer diagnosis. J. Nucl. Med. 63 (11), 1644\u20131650. https:\/\/doi.org\/10.2967\/jnumed.121.263448 (2022).","journal-title":"J. Nucl. Med."},{"key":"86607_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.euros.2023.05.002","volume":"53","author":"BD Kelly","year":"2023","unstructured":"Kelly, B. D. et al. A novel risk calculator incorporating clinical parameters, multiparametric magnetic resonance imaging, and prostate-specific membrane antigen positron emission tomography for prostate cancer risk stratification before transperineal prostate biopsy. Eur. Urol. Open. Sci. 53, 90\u201397. https:\/\/doi.org\/10.1016\/j.euros.2023.05.002 (2023).","journal-title":"Eur. Urol. Open. Sci."},{"issue":"1","key":"86607_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1148\/radiol.2020190646","volume":"296","author":"AC Westphalen","year":"2020","unstructured":"Westphalen, A. C. et al. Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease-focused panel. Radiology 296 (1), 76\u201384. https:\/\/doi.org\/10.1148\/radiol.2020190646 (2020).","journal-title":"Radiology"},{"issue":"12","key":"86607_CR14","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1007\/s00261-023-04011-y","volume":"48","author":"L Xiang","year":"2023","unstructured":"Xiang, L. et al. Patient-related characteristics predict prostate cancers in men with PI-RADS 4\u20135 to further optimize the diagnostic performance of MRI. Abdom. Radiol.  48 (12), 3766\u20133773. https:\/\/doi.org\/10.1007\/s00261-023-04011-y (2023).","journal-title":"Abdom. Radiol. (NY)"},{"issue":"2","key":"86607_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/aja2022112","volume":"25","author":"YH Wang","year":"2023","unstructured":"Wang, Y. H. et al. Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy. Asian J. Androl. 25 (2), 217\u2013222. https:\/\/doi.org\/10.4103\/aja2022112 (2023).","journal-title":"Asian J. Androl."},{"issue":"1","key":"86607_CR16","doi-asserted-by":"publisher","first-page":"e220762","DOI":"10.1148\/radiol.220762","volume":"307","author":"V Stavrinides","year":"2023","unstructured":"Stavrinides, V. et al. Regional histopathology and prostate MRI positivity: a secondary analysis of the PROMIS trial. Radiology 307 (1), e220762. https:\/\/doi.org\/10.1148\/radiol.220762 (2023).","journal-title":"Radiology"},{"issue":"2","key":"86607_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.eururo.2020.04.029","volume":"78","author":"JM Norris","year":"2020","unstructured":"Norris, J. M. et al. What type of prostate cancer is systematically overlooked by multiparametric magnetic resonance imaging? An analysis from the PROMIS cohort. Eur. Urol. 78 (2), 163\u2013170. https:\/\/doi.org\/10.1016\/j.eururo.2020.04.029 (2020).","journal-title":"Eur. Urol."},{"issue":"1","key":"86607_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/jcm12010339","volume":"12","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Nomograms combining PHI and PI-RADS in detecting prostate cancer: a multicenter prospective study. J. Clin. Med. 12 (1), 339. https:\/\/doi.org\/10.3390\/jcm12010339 (2023).","journal-title":"J. Clin. Med."},{"key":"86607_CR19","doi-asserted-by":"publisher","first-page":"1068893","DOI":"10.3389\/fonc.2022.1068893","volume":"12","author":"LC Mo","year":"2022","unstructured":"Mo, L. C. et al. Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI. Front. Oncol. 12, 1068893. https:\/\/doi.org\/10.3389\/fonc.2022.1068893 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"86607_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.semnuclmed.2023.10.002","volume":"54","author":"M Caracciolo","year":"2024","unstructured":"Caracciolo, M. et al. PSMA PET\/CT versus mpMRI for the detection of clinically significant prostate cancer: an updated overview. Semin. Nucl. Med. 54 (1), 30\u201338. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.10.002 (2024).","journal-title":"Semin Nucl. Med."},{"issue":"12","key":"86607_CR21","doi-asserted-by":"publisher","first-page":"e2138550","DOI":"10.1001\/jamanetworkopen.2021.38550","volume":"4","author":"M Xiang","year":"2021","unstructured":"Xiang, M. et al. Performance of a prostate-specific membrane antigen positron emission tomography\/computed tomography-derived risk-stratification tool for high-risk and very high-risk prostate cancer. JAMA Netw. Open. 4 (12), e2138550. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.38550 (2021).","journal-title":"JAMA Netw. Open."},{"issue":"7","key":"86607_CR22","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.21037\/tau-22-832","volume":"12","author":"C Cheng","year":"2023","unstructured":"Cheng, C. et al. Prediction of clinically significant prostate cancer using a novel 68Ga-PSMA PET-CT and multiparametric MRI-based model. Transl. Androl. Urol. 12 (7), 1115\u20131126. https:\/\/doi.org\/10.21037\/tau-22-832 (2023).","journal-title":"Transl Androl. Urol."},{"issue":"24","key":"86607_CR23","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.3390\/cancers15245838","volume":"15","author":"OM Tayara","year":"2023","unstructured":"Tayara, O. M. et al. Comparison of multiparametric MRI, [68Ga]Ga-PSMA-11 PET-CT, and clinical nomograms for primary T and N staging of intermediate-to-high-risk prostate cancer. Cancers (Basel)  15 (24), 5838. https:\/\/doi.org\/10.3390\/cancers15245838 (2023).","journal-title":"Cancers (Basel)"},{"issue":"12","key":"86607_CR24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.12998\/wjcc.v7.i12.1403","volume":"7","author":"NZ Xing","year":"2023","unstructured":"Xing, N. Z. et al. Feasibility of prostatectomy without prostate biopsy in the era of new imaging technology and minimally invasive techniques. World J. Clin. Cases  7 (12), 1403\u20131409. https:\/\/doi.org\/10.12998\/wjcc.v7.i12.1403 (2023).","journal-title":"World J. Clin. Cases"},{"issue":"4","key":"86607_CR25","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/cancers15041266","volume":"15","author":"M Chaloupka","year":"2023","unstructured":"Chaloupka, M. et al. Radical prostatectomy without prior biopsy in patients with high suspicion of prostate cancer based on multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography: a prospective cohort study. Cancers (Basel)  15 (4), 1266. https:\/\/doi.org\/10.3390\/cancers15041266 (2023).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"86607_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00345-024-04894-6","volume":"42","author":"F Falkenbach","year":"2024","unstructured":"Falkenbach, F. et al. PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy? World J. Urol. 42 (1), 182. https:\/\/doi.org\/10.1007\/s00345-024-04894-6 (2024).","journal-title":"World J. Urol."},{"issue":"1","key":"86607_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41824-023-00182-5","volume":"7","author":"AP Sharma","year":"2023","unstructured":"Sharma, A. P. et al. Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway. Eur. J. Hybrid. Imaging  7 (1), 24. https:\/\/doi.org\/10.1186\/s41824-023-00182-5 (2023).","journal-title":"Eur. J. Hybrid. Imaging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86607-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86607-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86607-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:11:24Z","timestamp":1741209084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86607-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86607"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86607-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4695012\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"6 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study protocol was reviewed and approved by the institutional review board of the Second Hospital of Tianjin Medical University Hospital (No.KY2020K130). Informed consent was submitted by all subjects when they were enrolled.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Institutional Review Board approval was obtained (No.KY2020K130).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}}],"article-number":"2506"}}